InvestorsHub Logo
icon url

Grip it and Sip It

05/06/19 8:17 AM

#40510 RE: Amatuer17 #40509

You gave two different predictions for mono approval... are you just shooting from the hip?

Grip
icon url

ohm20

05/06/19 9:04 AM

#40514 RE: Amatuer17 #40509

1 year enrollment for 300 patients with 12 recruiting sites seems overly long.
icon url

81vette

05/06/19 10:27 AM

#40523 RE: Amatuer17 #40509

$40pps when the drug is approved , wont do any good to buy it then, for now the 50% to 100%+ potential is the play
icon url

finesand

05/06/19 2:20 PM

#40537 RE: Amatuer17 #40509

A17 - I was expecting this 'news' more than 6 month ago, i.e. finally ending the non pivotal Monotherapy trial.
After all, it is costly to run trials w/o goals.

What they didn't say was: Safety data completed ..
And thereby they highly likely need the new pivotal monotherapy trial for safety to complete the Combo BLA.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148587372